logo
The mystery of the first potatoes has finally been solved – and a tomato was involved

The mystery of the first potatoes has finally been solved – and a tomato was involved

Yahoo2 days ago
The potato, a global food staple first cultivated thousands of years ago in the Andes region of South America before its worldwide spread from the 16th century, has long presented a puzzling evolutionary mystery.
Now, a new analysis has finally unravelled its origins.
Scientists have revealed that the potato lineage emerged approximately nine million years ago in South America, through a natural interbreeding event between a wild tomato plant and a potato-like species. This significant discovery, based on the genomic analysis of 450 cultivated potatoes and 56 wild species, explains how this vital crop came to be.
This ancient hybridisation event is understood to have led to the appearance of the nascent potato plant's distinctive tuber – the enlarged structure housing nutrients underground, according to the researchers. While the edible part of a tomato plant is its fruit, the potato's value lies in this subterranean growth. The study also identified two crucial genes involved in tuber formation, deepening our understanding of this essential crop.
"Potatoes are truly one of humanity's most remarkable food staples, combining extraordinary versatility, nutritional value and cultural ubiquity in ways few crops can match," said Sanwen Huang, a genome biologist and plant breeder at the Chinese Academy of Agricultural Sciences and senior author of the study published on Friday in the journal Cell.
"People eat potatoes using virtually every cooking method - baking, roasting, boiling, steaming and frying. Despite being stereotyped as carbohydrates, potatoes offer vitamin C, potassium, fiber and resistant starch, and are naturally gluten-free, low-fat and satiating - a nutrient-dense calorie source," Huang added.
Resistant starch is a type of carbohydrate that resists digestion in the small intestine and ferments in the large intestine, feeding beneficial bacteria in the gut.
The modern-day potato plant's scientific name is Solanum tuberosum. Its two parents identified in the study were plants that were the ancestors of a potato-like species now found in Peru named Etuberosum, which closely resembles the potato plant but lacks a tuber, and the tomato plant.
These two plants themselves shared a common ancestor that lived about 14 million years ago, and were able to naturally interbreed when the fortuitous hybridization event occurred five million years after they had diverged from each other.
"This event led to a reshuffling of genes such that the new lineage produced tubers, allowing these plants to expand into the newly created cold, dry habitats in the rising Andes mountain chain," said botanist Sandra Knapp of the Natural History Museum in London, a co-author of the study.
This hybridization event coincided with the rapid uplift of the Andes. With a tuber, the potato plant was able to adapt to the changing regional environment and thrive in the harsh conditions of the mountains.
"Tubers can store nutrients for cold adaptation, and enable asexual reproduction to meet the challenge of the reduced fertility in cold conditions. These allowed the plant to survive and rapidly expand," Huang said.
The study's findings, according to the researchers, may help guide improved cultivated potato breeding to address environmental challenges that crops presently face due to factors such as climate change.
There currently are roughly 5,000 potato varieties. The potato is the world's third most important food crop, after rice and wheat, for human consumption, according to the Peru-based International Potato Center research organization. China is the world's leading potato producer.
"It always is hard to remove all the deleterious mutations in potato genomes in breeding, and this study opens a new door to make a potato free of deleterious mutations using the tomato as the chassis of synthetic biology," Huang said.
The study also may open the door to generate a new crop species that could produce tomato fruit above ground and potato tubers below ground, according to Zhiyang Zhang, a postdoctoral researcher at the Chinese Academy of Agricultural Sciences.
The potato and tomato are members of the nightshade family of flowering plants that also includes tobacco and peppers, among others. The study did not investigate the evolutionary origins of other tuberous root crops that originated in South America such as the sweet potato and yuca, which are members of different families of flowering plants.
While the parts of the tomato and potato plants that people eat are quite different, the plants themselves are very similar.
"We use different parts of these two species, fruits in tomatoes and tubers in potatoes," Knapp said. "If you look at the flowers or leaves, these are very similar. And if you are lucky enough to let your potato plant produce fruits, they look just like little green tomatoes. But don't eat them. They are not very nice."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Astronomers witness a newborn planet emerging from the dust around a sun-like star: Space photo of the week
Astronomers witness a newborn planet emerging from the dust around a sun-like star: Space photo of the week

Yahoo

time17 hours ago

  • Yahoo

Astronomers witness a newborn planet emerging from the dust around a sun-like star: Space photo of the week

When you buy through links on our articles, Future and its syndication partners may earn a commission. QUICK FACTS What it is: A potential planet around the star HD 135344B Where it is: 440 light-years away, in the constellation Lupus When it was shared: July 21, 2025 Deep within a swirling disk of gas and dust around the star HD 135344B, a young planet appears to be sculpting intricate spiral arms around its stellar host. It is the first time a planet has been found embedded inside a dust spiral around a star, actively shaping its environment. The discovery is further proof that the building blocks of planets emerge from protoplanetary disks — giant, doughnut-shaped disks of gas and dust that circle young stars, according to NASA. These dense, rotating clouds of material around young stars have been seen to feature rings and spirals suspected to be caused by the presence of baby planets, but this is the first direct evidence. In fact, the sculpted protoplanetary disk around the host star, HD 135344B, had been seen before by astronomers using the SPHERE (Spectro-Polarimetric High-contrast Exoplanet Research) instrument on the European Southern Observatory's Very Large Telescope in Chile. However, by using a new instrument called the Enhanced Resolution Imager and Spectrograph (ERIS), scientists finally discovered a planetary candidate. The planet is nestled at the base of one spiral arm — exactly where models predicted a planet would be needed to generate such a feature — and is thought to be twice the size of Jupiter. It's about as far from its host star as Neptune is from the sun, or about 30 times the distance from Earth to the sun. "What makes this detection potentially a turning point is that, unlike many previous observations, we are able to directly detect the signal of the protoplanet, which is still highly embedded in the disc," Francesco Maio, a doctoral researcher at the University of Florence and lead author of a study describing the discovery, said in a statement. Related: 32 alien planets that really exist The existence of many exoplanets — planets that orbit a star other than the sun — is inferred from other information, such as the dip in a star's brightness that is assumed to be caused by a planet. Observing the planet's own light — reflected light from its host star — gives the proto-planet's discoverers a much higher level of confidence in its existence. MORE SPACE PHOTOS —'Fighting dragons' light up little-known constellation in the Southern sky —James Webb and Hubble telescopes join forces to explore a cosmic nursery —James Webb telescope reveals dizzying galaxies in the Bullet Cluster "We will never witness the formation of Earth, but here, around a young star 440 light-years away, we may be watching a planet come into existence in real time," Maio said. ERIS had a similarly decisive role in another recent discovery. Using ERIS, astronomers found an object — possibly a brown dwarf, an object halfway between a giant planet and a small star — in the protoplanetary disk around the young star V960 Mon, located 5,000 light-years away, in the constellation Monoceros. For more sublime space images, check out our Space Photo of the Week archives. Solve the daily Crossword

Vera Rubin Observatory glows under recalibration LEDs
Vera Rubin Observatory glows under recalibration LEDs

Yahoo

time18 hours ago

  • Yahoo

Vera Rubin Observatory glows under recalibration LEDs

When you buy through links on our articles, Future and its syndication partners may earn a commission. Named in honor of female astronomer Vera Rubin, whose pioneering work on galaxy rotation provided key evidence for dark matter, the Vera Rubin Observatory uses the world's largest digital camera to peer at the night sky, looking for dark matter in our universe. What is it? This state-of-the-art facility houses the Simonyi Survey Telescope, which includes a 27.5 foot (8.4 meters) primary mirror. Inside the dome, Rubin uses special recalibration lights to check and correct for variations in the sensors and other instruments. These lights help engineers map uneven pixel responses and find shadows or other irregularities. Where is it? The Vera Rubin Observatory sits atop the mountain Cerro Pachón in northern Chile. Why is it amazing? The rings in the calibration lights correspond to machining marks from the precision-shaped reflector which helps to spread light more evenly across the screen, according to NOIRLab. As the Rubin Observatory has begun its 10-year long Legacy Survey of Space and Time (LSST), hunting for dark matter in the universe so astronomers can determine what it is, its recalibrations become important to ensure the telescope is functioning properly. The calibration also helps astronomers find what are genuine cosmic anomalies versus instrumental error, allowing them to zero in on reliable data for their research. Want to learn more? You can read more about the Vera Rubin Observatory and its hunt for dark matter. Solve the daily Crossword

Meet The Biotech Startup Challenging Ozempic With A Fat-Burning Pill That Lets You Keep Eating
Meet The Biotech Startup Challenging Ozempic With A Fat-Burning Pill That Lets You Keep Eating

Yahoo

time20 hours ago

  • Yahoo

Meet The Biotech Startup Challenging Ozempic With A Fat-Burning Pill That Lets You Keep Eating

Imagine shedding weight while sitting quietly watching TV, even without cutting calories. A pioneering pill called SANA, created by Uruguayan startup Eolo Pharma, could one day make that possible. Early human data in a statement by Eolo Pharma shows it can burn fat even at rest, without appetite suppression or serious side effects. That breakthrough could reshape global obesity treatment. Biotech Startup Pioneers First-in-Class Therapies to Treat Obesity and Metabolic Disease Eolo Pharma is a clinical-stage biotechnology company focused on pioneering therapies for obesity and metabolic diseases. The company says it develops first-in-class small-molecule drugs that activate the body's own energy-burning pathways rather than relying on appetite suppression. Its lead candidate, SANA, is the first compound shown to safely activate creatine-dependent thermogenesis in humans, offering a novel approach to resetting metabolic health. Don't Miss: Accredited Investors: Grab Pre-IPO Shares of the AI Company Powering Hasbro, Sephora & MGM— 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can Headquartered in Delaware with strong scientific roots in South America, Eolo Pharma is a spin-off of the Institut Pasteur de Montevideo, a non-profit foundation that promotes scientific and technological research. The company says it is backed by more than a decade of research into metabolic disorders and cardiometabolic complications. Eolo Pharma's proprietary library of 60 novel chemical entities includes molecules designed to address high-burden, non-communicable diseases such as obesity, type 2 diabetes, non-alcoholic steatohepatitis, hypertension, amyotrophic lateral sclerosis, and Alzheimer's disease. Eolo Pharma's leadership team includes CEO María Pía Garat, a biotech industry leader with a postgraduate degree from Instituto de Empresa Business School; co-founder and Chief Scientific Officer Carlos Escande, a former Mayo Clinic investigator specializing in cardiometabolic disorders; Chief Chemistry Officer Virginia Lopez, a chemist from Uruguay; and Chief Medical Officer Carlos Batthyany, who also serves as head of the Institut Pasteur de Montevideo. Trending: $100k+ in investable assets? – no cost, no obligation. How SANA Activates Fat Burning Without Appetite Suppression SANA is a salicylate‑based nitroalkene compound originally developed to target inflammation, Eolo Pharma says. It was repurposed after researchers discovered it stimulates creatine‑dependent thermogenesis in white and brown fat cells. Unlike glucagon-like peptide‑1 drugs like Ozempic, which reduce hunger, SANA boosts energy expenditure in fat tissue by turning on heat‑producing metabolic pathways at cellular level. According to Eolo Pharma, SANA protected lean mass and reduced fat more than standard salicylate or metformin in preclinical models. "This is the first time a drug has been shown to pharmacologically activate creatine-based thermogenesis, which could lead to a novel therapeutic approach for obesity in humans," Escande said in the statement. "It opens up an entirely new therapeutic pathway for obesity and metabolic disorders."Weight Loss, Glucose Benefits, and Safety Signals In a randomized, double‑blind, placebo‑controlled Phase 1a/b clinical trial, participants received single ascending doses or multiple ascending doses of SANA for 15 days. The trial included 17 healthy lean volunteers and 24 individuals with obesity. According to Eolo Pharma, patients receiving SANA experienced a statistically significant reduction in body weight compared to placebo, along with improvements in fasting glucose and insulin resistance as measured by Homeostatic Model Assessment of Insulin Resistance. No serious adverse events occurred, and only mild headaches and soft stools were reported in some subjects. A Nature Metabolism study published in June describes SANA as a first‑in‑class small molecule that activates creatine‑dependent thermogenesis in preclinical models and shows safety and early metabolic benefits in a phase 1A/B trial in humans. The authors suggest SANA as a promising therapeutic candidate for obesity, though they note that its efficacy in humans requires further confirmation in larger trials. Read Next: The average American couple has saved this much money for retirement —? Image: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article Meet The Biotech Startup Challenging Ozempic With A Fat-Burning Pill That Lets You Keep Eating originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store